Odonate

ODTC · OTC

$50,000.00−$126,040.00 (−71.60%)TodayMarket closed ·
No price history for this range.

About ODTC

Odonate, Inc. is a pharmaceutical company, which engages in the development of therapeutics that improve and extend the lives of patients with cancer. The firm is focused on the development of tesetaxel, an investigational, orally administered chemotherapy agent that belongs to a class of drugs known as taxanes, which are used in the treatment of cancer. The firm is no longer in development of tesetax.

Employees
137
Headquarters
San Diego, Texas
Listed
Dec 7, 2017
Sector
Health Care
Industry
Pharmaceuticals

ODTC key statistics

Market cap
52.65M
Price-earnings ratio
—
Dividend yield
—
Average volume
180
Volume
1
Open price
$50,000.00
High today
$150,000.00
Low today
$150,000.00
52 Week high
$4,840.00
52 Week low
$3,000.00

Odonate (ODTC) at a glance

As of Feb 4, 2025, Odonate (ODTC) shares are priced at $50,000.00, giving the company a market cap of 52.65M.

Volume so far is 1 shares, below the average of 180 shares a day.

Over the past year Odonate has ranged from $3,000.00 to $4,840.00, and now sits 2554% of the way up that range.

Odonate met or beat analyst EPS estimates in 4 of the last 8 quarters. In Q2 FY21 it reported -$46,400.00 per share against an estimate of -$26,954.93.

ODTC earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 4 of the last 8 quarters, by 9.5% on average.

  1. Q3 FY19: reported -$70,400.00 per share against an estimate of -$86,224.27
  2. Q4 FY19: reported -$72,000.00 per share against an estimate of -$80,845.20
  3. Q1 FY20: reported -$79,200.00 per share against an estimate of -$83,150.40
  4. Q2 FY20: reported -$87,200.00 per share against an estimate of -$79,886.40
  5. Q3 FY20: reported -$74,400.00 per share against an estimate of -$77,622.00
  6. Q4 FY20: reported -$66,400.00 per share against an estimate of -$63,852.00
  7. Q1 FY21: reported -$72,000.00 per share against an estimate of -$65,987.47
  8. Q2 FY21: reported -$46,400.00 per share against an estimate of -$26,954.93

Similar companies

Companies in the same industry as Odonate

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.